Products for Research Use Only
RegisterLogin

Linagliptin

CAT: 0013-GTR19176373-02Size: 1 ml x 10 mM (in DMSO)Dry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19176373-02Size:1 ml x 10 mM (in DMSO)
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Linagliptin (BI 1356) is a potent and orally bioavailable DPP-4 inhibitor of the dihydropurinedione class, used for its hypoglycemic effects. It is widely applied in diabetes research, including in vitro enzymatic assays and in vivo studies of glucose metabolism and pancreatic function.
CAS Number
668270-12-0
Product Name Alternative
Dipeptidyl Peptidase, DPP, DPP4, DPP-4, Autophagy, BI 1356, BI1356, BI-1356, Inhibitor, Ferroptosis, inhibit, Linagliptin
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.15% (May vary between batches)
Solubility
DMSO:26.67 mg/mL (56.44 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.12 mM) ; Ethanol:1 mg/mL (2.12 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
C (C#CC) N1C2=C (N=C1N3C[C@H] (N) CCC3) N (C) C (=O) N (CC4=NC5=C (C (C) =N4) C=CC=C5) C2=O
Molecular Formula
C25H28N8O2
Molecular Weight
472.54
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Linagliptin

Linagliptin is a xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes. It has a role as a hypoglycemic agent and an EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor. It is a member of quinazolines and an aminopiperidine. It is functionally related to a 7H-xanthine.

CAS Number668270-12-0
PubChem CID10096344
IUPAC Name8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
Molecular FormulaC25H28N8O2
Molecular Weight472.5
XLogP1.9
Topological Polar Surface Area113
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Heavy Atom Count35
Formal Charge0
Complexity885
SMILES
CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C
InChI
InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1
InChIKey
LTXREWYXXSTFRX-QGZVFWFLSA-N
Chemical Structure
2D Structure
2D structure of Linagliptin
CAS: 668270-12-0
CID: 10096344
Formula: C25H28N8O2
MW: 472.5
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight472.5
XLogP31.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass472.23352217
Monoisotopic Mass472.23352217
Topological Polar Surface Area113 Ų
Heavy Atom Count35
Formal Charge0
Complexity885
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
T0191-01Linagliptin
RM-L140720-01Linagliptin Impurity T (Linagliptin Methyldimer)
HY-10284R-01Linagliptin (Standard)
TRC-L465902-1MGLinagliptin-d3

Popular Products